Literature DB >> 6765418

Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.

F Crokaert, M P van der Linden, E Yourassowsky.   

Abstract

Urinary tract infection caused by beta-lactamase-producing bacteria were treated with 500 mg of amoxicillin three times daily plus either 250 or 125 mg of clavulanic acid three times daily. The overall cure rate was 63.6%, 77.7% with the high dose of clavulanic acid and 53.8% with the low dose. Gastrointestinal intolerance was common in the high-dose clavulanic acid regimen.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6765418      PMCID： PMC183740          DOI： 10.1128/AAC.22.2.346

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.

Authors:  L Dumon; P Adriaens; J Anné; H Eyssen
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

3.  Antibody-coated bacteria in the urine and the site of urinary-tract infection.

Authors:  V Thomas; A Shelokov; M Forland
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.

Authors:  A P Ball; A M Geddes; P G Davey; I D Farrell; G R Brookes
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

6.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors:  G Ninane; J Joly; M Kraytman; P Piot
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

8.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  [Kinetics of beta-lactamase inhibition by clavulanic acid].

Authors:  R Labia; J Peduzzi
Journal:  Biochim Biophys Acta       Date:  1978-10-12

10.  Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.

Authors:  R Martinelli; A A Lopes; M M de Oliveira; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191
View more
  6 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings.

Authors:  F Caron; P Ducrotte; E Lerebours; R Colin; G Humbert; P Denis
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

4.  Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy.

Authors:  S J Pedler; A J Bint
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

5.  In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Authors:  P C Fuchs; A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

6.  Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.

Authors:  M J Gurwith; G E Stein; D Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.